drugset / Trial / NCT07113392
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety, efficacy and pharmacokinetics of Suraxavir Marboxil compared with oseltamivir in Pediatric Patients (2 to \<12 Years) with Uncomplicated Influenza.
Timeline
- Start
- 2025-08-01
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Oseltamivir | Small molecule | 30 mg | Oral |
| Comparator | Oseltamivir | Small molecule | 45 mg | Oral |
| Comparator | Oseltamivir | Small molecule | 60 mg | Oral |
| Comparator | Oseltamivir | Small molecule | 75 mg | Oral |
| Subject | Suraxavir marboxil | Unknown | 20 mg | Oral |
| Subject | Suraxavir marboxil | Unknown | 40 mg | Oral |